Catherine Roche‐Lestienne

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

Catherine Roche‐Lestienne, Valérie Soenen, Nathalie Grardel et al. · Blood · 2002 · 517 citations · Full text

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Claude Preudhomme, Joëlle Guilhot, Franck E. Nicolini et al. · New England Journal of Medicine · 2010 · 382 citations

MYD88 L265P mutation in Waldenstrom macroglobulinemia

Stéphanie Poulain, Christophe Roumier, Audrey Decambron et al. · Blood · 2013 · 228 citations · Full text

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA–positive chronic eosinophilic leukemia

Jelena Jovanović, Joannah Score, Katherine Waghorn et al. · Blood · 2007 · 204 citations · Full text

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

Franck E. Nicolini, Sélim Corm, Q.H. Le et al. · Leukemia · 2006 · 203 citations

Hematological Malignancy, Medicine, Hematology +9